Industry »Biotechnology« (258)
Filter by Size, Price, EPS, Revenue, Debt, Returns and many other Dividend and Fundamental Data.
Results
258 matches
| SYMBOL | INDUSTRY | MKT CAP | VRT | SIGNAL | SAFETY | RS | DIV. YIELD |
|---|---|---|---|---|---|---|---|
| VRTX NASDAQ Vertex Pharmaceuticals |
Biotechnology
Cystic Fibrosis, Sickle Cell, Acute Pain, Gene |
134B | 62 | 0.46 | 86 | 64 | - |
| REGN NASDAQ Regeneron Pharmaceuticals |
Biotechnology
Ophthalmology, Immunology, Oncology, Cholesterol |
68.6B | 56 | -0.09 | 85 | 25 | 0.5% |
| ARGX BR Argen-X |
Biotechnology
Vyvgart, Vyvgart Hytrulo, Efgartigimod |
58.9B | 70 | 0.62 | 77 | 77 | - |
| ARGX NASDAQ argenx |
Biotechnology
Autoimmune Therapies, Neurology Drugs, Immunology |
58.1B | 73 | 0.59 | 89 | 77 | - |
| UCB BR UCB |
Pharmaceuticals
Neurology, Immunology, Epilepsy, Allergies |
56.3B | 60 | -0.23 | 86 | 43 | 0.4% |
| ALNY NASDAQ Alnylam Pharmaceuticals |
Biotechnology
Amyloidosis, Hypercholesterolemia, Hemophilia |
41.8B | 48 | -0.31 | 63 | 12 | - |
| RVMD NASDAQ Revolution Medicines |
Biotechnology
Targeted Oncology, Ras Inhibitors, Precision |
40.2B | 41 | 0.65 | 85 | 99 | - |
| RPRX NASDAQ Royalty Pharma |
Pharmaceuticals
Biopharmaceutical Royalties, Rare Disease |
33.3B | 55 | 0.98 | 44 | 87 | 2.1% |
| MRNA NASDAQ Moderna |
Biotechnology
Respiratory Vaccines, Oncology Therapeutics, Rare |
32.8B | 49 | 1.03 | 93 | 98 | - |
| ONC NASDAQ BeiGene |
Biotechnology
Oncology, Immunotherapy, BTK Inhibitors, Antibody |
30.2B | 63 | 0.08 | 83 | 32 | - |
| ROIV NASDAQ Roivant Sciences |
Biotechnology
Autoimmune Therapies, Pulmonary Treatments |
25.3B | 39 | 1.21 | 46 | 97 | - |
| INSM NASDAQ Insmed |
Biotechnology
Inhaled Antibiotics, DPP1 Inhibitor, Pulmonary |
24.2B | 22 | -0.32 | 30 | 5 | - |
| BNTX NASDAQ BioNTech SE |
Biotechnology
Mrna Vaccines, Oncology Therapies, Infectious |
23.8B | 32 | -0.39 | 93 | 19 | - |
| INCY NASDAQ Incyte |
Biotechnology
Oncology, Dermatology, JAK Inhibitors, Kinase |
23.3B | 75 | 0.69 | 94 | 82 | - |
| GMAB CO Genmab |
Biotechnology
Oncology, Hematology, Solid Tumors, Antibody |
17.6B | 45 | 0.54 | 30 | 38 | - |
| ASND NASDAQ Ascendis Pharma AS |
Biotechnology
SKYTROFA, YORVIPATH, Endocrinology, Oncology |
17.6B | 48 | 0.29 | 38 | 78 | - |
| GMAB NASDAQ Genmab AS |
Biotechnology
Antibody Therapeutics, Oncology, Hematology |
16.9B | 39 | -0.37 | 22 | 38 | - |
| JAZZ NASDAQ Jazz Pharmaceuticals |
Pharmaceuticals
Sleep Disorders, Epilepsy, Oncology, Rare Diseases |
15.3B | 60 | 1.41 | 78 | 93 | - |
| BBIO NASDAQ BridgeBio Pharma |
Biotechnology
Cardiomyopathy, Genetic Diseases, Gene Therapy |
15.2B | 32 | -0.02 | 35 | 78 | - |
| EXEL NASDAQ Exelixis |
Biotechnology
Cabometyx, Cometriq, Cotellic, Minnebro |
13.6B | 70 | 1.14 | 91 | 80 | - |
| IONS NASDAQ Ionis Pharmaceuticals |
Biotechnology
RNA Medicines, Rare Diseases, Neurological |
13.5B | 52 | 0.02 | 68 | 82 | - |
| AXSM NASDAQ Axsome Therapeutics |
Pharmaceuticals
Depression Treatment, Sleep Disorder Therapy |
12.6B | 39 | 1.30 | 37 | 95 | - |
| MDGL NASDAQ Madrigal Pharmaceuticals |
Biotechnology
Rezdiffra, MASH Therapy, Liver Treatment, Thyroid |
12.2B | 34 | -0.51 | 33 | 74 | - |
| SMMT NASDAQ Summit Therapeutics |
Biotechnology
Bispecific Antibody, Cancer Immunotherapy, Lung |
12.0B | 18 | -0.21 | 80 | 6 | - |
| ARWR NASDAQ Arrowhead Pharmaceuticals |
Biotechnology
RNAi Therapeutics, Metabolic Diseases, Liver |
11.8B | 37 | 0.79 | 38 | 98 | - |
| CYTK NASDAQ Cytokinetics |
Biotechnology
HCM Treatments, Heart Failure, Muscle Activators |
11.7B | 39 | 0.43 | 37 | 92 | - |
| ABVX PA Abivax |
Biotechnology
Obefazimod, Ulcerative Colitis, Crohns Disease |
11.5B | 49 | 0.58 | 83 | 99 | - |
| ABVX NASDAQ Abivax American Depositary |
Biotechnology
Ulcerative Colitis, Crohns Disease, Inflammatory |
11.5B | 48 | 0.75 | 78 | 99 | - |
| BMRN NASDAQ Biomarin Pharmaceutical |
Biotechnology
Enzyme Therapies, Rare Diseases, Metabolic |
11.4B | 41 | 0.06 | 88 | 38 | - |
| KRYS NASDAQ Krystal Biotech |
Biotechnology
Gene Therapy, Dermatology, Cystic Fibrosis |
11.1B | 67 | 0.91 | 78 | 95 | - |
| TECH NASDAQ Bio-Techne |
Life Sciences Tools
Life Science Reagents, Diagnostic Assays, Protein |
11.0B | 59 | 0.14 | 89 | 75 | 0.6% |
| APGE NASDAQ Apogee Therapeutics, Common |
Biotechnology
Biologics, Monoclonal Antibodies, Atopic |
9.99B | 46 | 1.41 | 79 | 98 | - |
| CORT NASDAQ Corcept Therapeutics |
Pharmaceuticals
Endocrine Medications, Metabolic Treatments |
9.83B | 60 | 1.52 | 95 | 96 | - |
| NUVL NASDAQ Nuvalent |
Biotechnology
Kinase Inhibitors, Lung Cancer, Targeted |
9.78B | 41 | 0.05 | 76 | 82 | - |
| HALO NASDAQ Halozyme Therapeutics |
Biotechnology
Drug Delivery, Oncology, Biologics, Hormones |
9.42B | 69 | 0.39 | 78 | 77 | - |
| KYMR NASDAQ Kymera Therapeutics |
Biotechnology
Protein Degradation, Immunology, Autoimmune |
9.39B | 50 | 1.13 | 78 | 96 | - |
| IBRX NASDAQ Immunitybio |
Biotechnology
Immunotherapies, Cytokine Fusion Proteins |
9.17B | 42 | 0.67 | 35 | 99 | - |
| PRAX NASDAQ Praxis Precision Medicines |
Biotechnology
Epilepsy, Essential Tremor, CNS Disorders |
8.88B | 47 | 1.00 | 70 | 99 | - |
| PTGX NASDAQ Protagonist Therapeutics |
Biotechnology
Psoriasis, Polycythemia Vera, Obesity, Atopic |
8.46B | 41 | 1.22 | 57 | 96 | - |
| ALK-B CO ALK-Abelló |
Biotechnology
Allergy Immunotherapy, Emergency Treatment |
8.27B | 74 | 0.47 | 90 | 62 | 0.8% |
| TGTX NASDAQ TG Therapeutics |
Biotechnology
BRIUMVI, Anti-CD20, BTK Inhibitor, Bispecific |
8.16B | 45 | 1.85 | 40 | 94 | - |
| PCVX NASDAQ Vaxcyte |
Biotechnology
Pneumococcal Vaccines, Strep Vaccines |
8.10B | 33 | 0.19 | 56 | 82 | - |
| IMVT NASDAQ Immunovant |
Biotechnology
Monoclonal Antibodies, Autoimmune Therapies |
7.91B | 45 | 1.03 | 77 | 96 | - |
| RYTM NASDAQ Rhythm Pharmaceuticals |
Biotechnology
Setmelanotide, Bivamelagon, RM-718, Rare Obesity |
7.83B | 37 | 0.07 | 41 | 81 | - |
| MIRM NASDAQ Mirum Pharmaceuticals |
Biotechnology
Liver Therapeutics, Hepatitis Treatment, Bile |
7.66B | 36 | 0.76 | 41 | 94 | - |
| SYRE NASDAQ Spyre Therapeutics |
Biotechnology
Inflammatory Bowel, Rheumatic Diseases |
7.52B | 42 | 1.18 | 58 | 99 | - |
| BANB SW Bachem Holding |
Chemicals
Peptide APIs, Oligonucleotides, NCEs, Generics |
7.04B | 56 | 0.94 | 96 | 74 | 0.6% |
| PTCT NASDAQ PTC Therapeutics |
Biotechnology
Muscular Dystrophy, Gene Therapy, Spinal Atrophy |
6.98B | 34 | 0.81 | 34 | 86 | - |
| COGT NASDAQ Cogent Biosciences |
Biotechnology
KIT Inhibitors, FGFR Inhibitors, ErbB2 |
6.61B | 47 | 1.17 | 73 | 97 | - |
| SRRK NASDAQ Scholar Rock Holding |
Biotechnology
Neuromuscular, Oncology, Fibrosis, Anemia |
6.58B | 41 | 0.03 | 81 | 80 | - |
| LGND NASDAQ Ligand Pharmaceuticals |
Biotechnology
Oncology, Infectious Disease, Vaccines, Rare |
6.25B | 59 | 1.27 | 90 | 96 | - |
| CGON NASDAQ CG Oncology, Common stock |
Biotechnology
Oncolytic Immunotherapy, Bladder Cancer, NMIBC |
6.11B | 35 | 0.04 | 42 | 92 | - |
| CRSP NASDAQ Crispr Therapeutics |
Biotechnology
Gene Editing, Cell Therapy, Hemoglobinopathies |
6.10B | 26 | -0.40 | 69 | 47 | - |
| DFTX NASDAQ Definium Therapeutics |
Pharmaceuticals
Anxiety Treatment, Depression Treatment, Autism |
5.99B | 44 | 1.26 | 70 | 99 | - |
| XENE NASDAQ Xenon Pharmaceuticals |
Biotechnology
Azetukalner, Epilepsy, Pain, Sodium Channel |
5.89B | 44 | 0.52 | 87 | 89 | - |
| BLTE NASDAQ Belite Bio |
Biotechnology
Tinlarebant, Retinal Disease, Liver Disease |
5.88B | 39 | -0.07 | 74 | 90 | - |
| LEGN NASDAQ Legend Biotech |
Biotechnology
Cell Therapies, CAR-T Therapies, Oncology |
5.79B | 25 | -0.12 | 52 | 66 | - |
| ERAS NASDAQ Erasca |
Biotechnology
Precision Oncology, RAS Inhibitors, KRAS |
5.74B | 42 | 0.80 | 79 | 99 | - |
| ORKA NASDAQ Oruka Therapeutics |
Biotechnology
Antibody Therapies, Psoriasis Treatments |
5.63B | 44 | 0.43 | 66 | 99 | - |
| MANE NYSE Veradermics |
Biotechnology
Hair Loss Therapy, Warts Treatment, Alopecia |
5.42B | 44 | 1.22 | 65 | 99 | - |
| DNTH NASDAQ Dianthus Therapeutics |
Biotechnology
Autoimmune Therapies, Monoclonal Antibodies |
5.33B | 52 | 0.83 | 80 | 99 | - |
| TVTX NASDAQ Travere Therapeutics |
Biotechnology
Kidney Therapies, Metabolic Treatments, Oral |
5.29B | 56 | 1.54 | 41 | 98 | - |
| CELC NASDAQ Celcuity |
Biotechnology
Gedatolisib, PI3K Inhibitors, Breast Cancer |
5.26B | 47 | 1.03 | 78 | 99 | - |
| CAI NASDAQ Caris Life Sciences, Common |
Life Sciences Tools
Molecular Profiling, Cancer Detection, Genome |
5.03B | 29 | -0.64 | 55 | 4 | - |
| TNGX NASDAQ Tango Therapeutics |
Biotechnology
Precision Oncology, Cancer Therapeutics, PRMT5 |
4.80B | 43 | 1.03 | 70 | 99 | - |
| CRNX NASDAQ Crinetics Pharmaceuticals |
Biotechnology
Paltusotine, Atumelnant, PTH Antagonists, GLP-1 |
4.43B | 37 | 0.00 | 37 | 98 | - |
| ACAD NASDAQ ACADIA Pharmaceuticals |
Biotechnology
Parkinsons Psychosis, Rett Syndrome, Alzheimers |
4.41B | 41 | 0.00 | 80 | 60 | - |
| EWTX NASDAQ Edgewise Therapeutics |
Biotechnology
Muscular Dystrophy, Hypertrophic Cardiomyopathy |
4.37B | 47 | 1.38 | 84 | 98 | - |
| VKTX NASDAQ Viking Therapeutics |
Biotechnology
Liver Disease Therapies, Metabolic Treatments |
4.35B | 32 | -0.12 | 68 | 82 | - |
| DNLI NASDAQ Denali Therapeutics |
Biotechnology
Neurodegenerative Treatments, Enzyme Therapies |
4.10B | 44 | 0.25 | 69 | 92 | - |
| RLAY NASDAQ Relay Therapeutics |
Biotechnology
Oncology, Genetic Disease, PI3K Inhibitor |
4.06B | 45 | 1.12 | 76 | 99 | - |
| NAMS NASDAQ NewAmsterdam Pharma |
Biotechnology
CETP Inhibitor, LDL-C Therapy, Cardiovascular |
3.96B | 31 | -0.05 | 40 | 75 | - |
| BEAM NASDAQ Beam Therapeutics |
Biotechnology
Genetic Medicines, Hematology Treatments, Liver |
3.83B | 41 | -0.36 | 72 | 92 | - |
| RCUS NYSE Arcus Biosciences |
Biotechnology
Oncology, Immuno-Oncology, Antibodies, Small |
3.81B | 40 | 0.02 | 35 | 97 | - |
| GPCR NASDAQ Structure Therapeutics |
Biotechnology
Obesity, Pulmonary Fibrosis, Glp-1 Agonists |
3.81B | 37 | 0.18 | 71 | 92 | - |
| PBLS NASDAQ Parabilis Medicines, Common |
Biotechnology | 3.74B | 10 | 0.37 | 43 | - | - |
| DYN NASDAQ Dyne Therapeutics |
Biotechnology
Muscle Therapies, Neuromuscular Treatments, FORCE |
3.67B | 49 | 0.47 | 81 | 94 | - |
| IDYA NASDAQ Ideaya Biosciences |
Biotechnology
Oncology, Kinase Inhibitors, Antibody Conjugates |
3.59B | 32 | -0.16 | 26 | 87 | - |
| ELVN NASDAQ Enliven Therapeutics |
Pharmaceuticals
Kinase Inhibitors, HER2 Inhibitors, Oncology |
3.56B | 44 | 1.31 | 70 | 98 | - |
| CAMX ST Camurus |
Pharmaceuticals
Buvidal, Brixadi, CAM2029, CAM4072 |
3.50B | 44 | -0.39 | 96 | 27 | - |
| ALMS NASDAQ Alumis |
Biotechnology
TYK2 Inhibitors, Monoclonal Antibodies |
3.48B | 41 | 1.40 | 30 | 99 | - |
| BION SW BB Biotech |
Biotechnology
Equity Fund, Biotechnology Investments |
3.36B | 55 | 0.91 | 45 | 84 | 5.3% |
| RARE NASDAQ Ultragenyx |
Biotechnology
Crysvita, Mepsevii, Dojolvi, Evkeeza |
3.30B | 23 | 0.50 | 38 | 82 | - |
| ARQT NASDAQ Arcutis Biotherapeutics |
Biotechnology
Topical Cream, Psoriasis Treatment, Atopic |
3.26B | 51 | -0.14 | 41 | 83 | - |
| ZEAL CO Zealand Pharma |
Biotechnology
Hypoglycemia Treatment, Artificial Pancreas |
3.18B | 38 | -0.26 | 33 | 10 | - |
| BIOA-B ST BioArctic (publ) |
Biotechnology
Alzheimer Treatment, Parkinson Research |
3.01B | 66 | 0.04 | 78 | 63 | 0.6% |
| CLDX NASDAQ Celldex Therapeutics |
Biotechnology
Barzolvolimab, CDX-622, Monoclonal Antibodies |
3.01B | 35 | 0.90 | 41 | 89 | - |
| VERA NASDAQ Vera Therapeutics |
Biotechnology
Fusion Protein, Monoclonal Antibody, Dual |
2.96B | 35 | -0.21 | 80 | 76 | - |
| SLS NASDAQ Sellas Life Sciences |
Biotechnology
Cancer Immunotherapy, Peptide Vaccines, CDK9 |
2.95B | 45 | 1.48 | 73 | 99 | - |
| IRON NASDAQ Disc Medicine |
Biotechnology
Anemia, Porphyria, Polycythemia, Hematology |
2.86B | 37 | -0.40 | 64 | 69 | - |
| KLRA NASDAQ Kailera Therapeutics |
Biotechnology
Obesity Therapies, Injectable Peptides, Oral |
2.85B | 24 | -0.26 | 48 | 9 | - |
| QURE NASDAQ Uniqure |
Biotechnology
Hemophilia B, Huntingtons Disease, Epilepsy, ALS |
2.84B | 42 | 0.92 | 46 | 97 | - |
| TARS NASDAQ Tarsus Pharmaceuticals |
Pharmaceuticals
Ophthalmic Solutions, Blepharitis Treatment |
2.82B | 41 | -0.39 | 70 | 58 | - |
| MBX NASDAQ MBX Biosciences, Common |
Biotechnology
Hypoparathyroidism Therapy, Hypoglycemia Therapy |
2.75B | 45 | 1.22 | 69 | 99 | - |
| TRVI NASDAQ Trevi Therapeutics |
Pharmaceuticals
Haduvio, Nalbuphine, Chronic Cough, Pulmonary |
2.55B | 40 | 0.90 | 67 | 97 | - |
| NRIX NASDAQ Nurix Therapeutics |
Biotechnology
BTK Degraders, CBL-B Inhibitors, IRAK4 Degraders |
2.48B | 43 | 0.11 | 60 | 95 | - |
| NTLA NASDAQ Intellia Therapeutics |
Biotechnology
Amyloidosis Treatment, Angioedema Treatment |
2.45B | 38 | 0.15 | 37 | 84 | - |
| IMNM NASDAQ Immunome |
Biotechnology
Oncology Drugs, Antibody Conjugates, Radioligand |
2.43B | 44 | 0.17 | 62 | 92 | - |
| KOD NASDAQ Kodiak Sciences |
Biotechnology
Retinal Therapies, Antibody Biopolymers, VEGF |
2.41B | 45 | 0.67 | 78 | 99 | - |
| ABCL NASDAQ Abcellera Biologics |
Biotechnology
Antibody Medicines, Monoclonal Antibodies |
2.40B | 49 | 0.50 | 64 | 97 | - |
| BHVN NYSE Biohaven |
Biotechnology
Immunology, Neuroscience, Oncology |
2.40B | 37 | 0.45 | 78 | 84 | - |
| VCEL NASDAQ Vericel Ord |
Biotechnology
Cartilage Repair, Burn Treatment, Skin |
2.40B | 59 | 0.65 | 75 | 80 | - |
| PHVS NASDAQ Pharvaris BV |
Biotechnology
Angioedema, Bradykinin, Hereditary Angioedema |
2.37B | 40 | 0.38 | 77 | 89 | - |
| MLYS NASDAQ Mineralys Therapeutics |
Biotechnology
Lorundrostat, Hypertension, Kidney Disease, Sleep |
2.37B | 34 | -0.69 | 61 | 70 | - |
| GENB NASDAQ Generate Biomedicines |
Biotechnology
Monoclonal Antibodies, CAR-T Therapy, Protein |
2.23B | 29 | -0.72 | 45 | 79 | - |
| MRVI NASDAQ Maravai Lifesciences |
Life Sciences Tools
Nucleic Acids, Oligonucleotides, ELISA Kits |
2.23B | 53 | 1.23 | 69 | 96 | - |
| AGIO NASDAQ Agios Pharm |
Biotechnology
Hemolytic Anemia, Sickle Cell, Thalassemia |
2.22B | 29 | 0.97 | 34 | 77 | - |
| BAVA CO Bavarian Nordic |
Biotechnology
Smallpox Vaccines, Rabies Vaccines, Encephalitis |
2.20B | 48 | 0.01 | 94 | 19 | - |
| NKTR NASDAQ Nektar Therapeutics |
Pharmaceuticals
Autoimmune Disorders, Oncology Treatments |
2.18B | 36 | 0.46 | 40 | 93 | - |
| ZLAB NASDAQ Zai Lab |
Biotechnology
Oncology, Immunology, Neuroscience, Infectious |
2.16B | 11 | -0.53 | 29 | 6 | - |
| HRMY NASDAQ Harmony Biosciences Holdings |
Pharmaceuticals
Narcolepsy Treatment, Sleep Disorders, Epilepsy |
2.16B | 58 | 0.83 | 94 | 77 | - |
| VRDN NASDAQ Viridian Therapeutics |
Biotechnology
Monoclonal Antibodies, Thyroid Therapies, FcRn |
2.14B | 37 | 0.11 | 71 | 63 | - |
| KARD NASDAQ Kardigan, Common Stock |
Biotechnology
Cardiovascular Medicines, Heart Failure Drugs |
2.14B | 24 | 0.00 | 74 | 36 | - |
| PVLA NASDAQ Palvella Therapeutics |
Biotechnology
Topical Rapamycin, Topical Pitavastatin, Rare |
2.10B | 41 | -0.21 | 58 | 98 | - |
| NBTX NASDAQ Nanobiotix |
Biotechnology
Nanoparticles, Cancer Therapeutics, Radiotherapy |
2.09B | 51 | 0.65 | 77 | 99 | - |
| ADMA NASDAQ ADMA Biologics |
Biotechnology
Immune Globulin, Hepatitis Antibodies, Plasma |
2.07B | 39 | -0.12 | 96 | 4 | - |
| OCUL NASDAQ Ocular Therapeutix |
Pharmaceuticals
Dexamethasone Insert, Axitinib Hydrogel |
2.07B | 22 | -0.48 | 80 | 40 | - |
| GLUE NASDAQ Monte Rosa Therapeutics |
Biotechnology
Oncology, Autoimmune, Inflammation, Neurology |
2.04B | 48 | 1.21 | 73 | 98 | - |
| STOK NASDAQ Stoke Therapeutics |
Biotechnology
Antisense Oligonucleotides, Dravet Syndrome |
2.04B | 36 | 0.37 | 44 | 85 | - |
| SRPT NASDAQ Sarepta Therapeutics |
Biotechnology
RNA Therapeutics, Gene Therapy, Duchenne |
2.04B | 40 | 0.33 | 65 | 14 | - |
| RXRX NASDAQ Recursion Pharmaceuticals |
Biotechnology
Oncology, Rare Diseases, AI Drug Discovery |
2.02B | 16 | -0.43 | 37 | 17 | - |
| IDIA SW Idorsia |
Biotechnology
Insomnia, Cardiovascular, Immunology, Orphan |
2.02B | 44 | 1.22 | 46 | 97 | - |
| AUPH NASDAQ Aurinia Pharmaceuticals |
Biotechnology
Lupus Therapy, Autoimmune Drugs, Oral Medication |
2.01B | 61 | 0.42 | 43 | 81 | - |
| LKFT NASDAQ Lakefront Biotherapeutics |
Biotechnology
Oncology, Immunology, CAR-T, Autoimmune |
2.00B | 43 | 0.36 | 61 | 45 | - |
| SION NASDAQ Sionna Therapeutics, Common |
Biotechnology
Cystic Fibrosis, CFTR Correctors, CFTR |
1.99B | 40 | -0.27 | 75 | 88 | - |
| LKFT AS LAKEFRONT BIOTHERAPEUTICS |
Biotechnology
Oncology, Immunology, Cell Therapy |
1.97B | 40 | 0.27 | 47 | 45 | - |
| ABSI NASDAQ Absci |
Biotechnology
Inflammatory Bowel Disease, Androgenic Alopecia |
1.97B | 42 | 1.32 | 70 | 99 | - |
| ZYME NASDAQ Zymeworks Common Stock |
Biotechnology
Bispecific Antibodies, Antibody-Drug Conjugates |
1.94B | 27 | 0.49 | 38 | 84 | - |
| SNDX NASDAQ Syndax Pharmaceuticals |
Biotechnology
Menin Inhibitors, CSF-1R Antibodies, HDAC |
1.93B | 34 | 0.04 | 26 | 86 | - |
| NANO PA Nanobiotix S.A |
Biotechnology
Oncology, Nanomedicine, Cancer Therapy |
1.93B | 44 | 0.59 | 81 | 99 | - |
| BCAX NASDAQ Bicara Therapeutics Common |
Biotechnology
Bifunctional Antibodies, Solid Tumor Therapy |
1.92B | 41 | 0.18 | 54 | 96 | - |
| ATAI NASDAQ ATAI Life Sciences BV |
Biotechnology
Psychedelic Therapies, Antidepressants, Mental |
1.91B | 40 | -0.24 | 35 | 84 | - |
| NUVB NYSE Nuvation Bio |
Biotechnology
Oncology, Lung Cancer, Brain Cancer, Targeted |
1.89B | 55 | -0.06 | 40 | 89 | - |
| TSHA NASDAQ Taysha Gene Therapies |
Biotechnology
Gene Therapies, Neurological Treatments, CNS |
1.88B | 46 | -0.18 | 82 | 93 | - |
| PGEN NASDAQ Precigen |
Biotechnology
Gene Therapies, Cell Therapies, Immunotherapy |
1.87B | 45 | 0.00 | 36 | 95 | - |
| RAPP NASDAQ Rapport Therapeutics |
Pharmaceuticals
Focal Epilepsy, Chronic Pain, Migraine, Hearing |
1.86B | 54 | -0.28 | 70 | 94 | - |
| URGN NASDAQ UroGen Pharma |
Biotechnology
Zusduri, Jelmyto, RTGel, UGN-103 |
1.85B | 50 | 1.02 | 42 | 98 | - |
| ANAB NASDAQ AnaptysBio |
Biotechnology
Antibody Therapeutics, Autoimmune Diseases |
1.84B | 58 | 1.49 | 41 | 99 | - |
| GHRS NASDAQ GH Research |
Biotechnology
Mebufotenin, Inhaled Therapy, Depression |
1.84B | 39 | 0.51 | 66 | 95 | - |
| TYRA NASDAQ Tyra Biosciences |
Biotechnology
Oncology, FGFR Inhibitors, Skeletal Disorders |
1.82B | 43 | 0.13 | 75 | 94 | - |
| GLPG AS Galapagos |
Biotechnology
Immunology Drugs, Oncology Drugs, Cell Therapies |
1.77B | 42 | -0.35 | 67 | 25 | - |
| IOVA NASDAQ Iovance Biotherapeutics |
Biotechnology
Cell Therapy, Interleukin, Oncology, Melanoma |
1.77B | 40 | 0.31 | 42 | 95 | - |
| AKTS NASDAQ Aktis Oncology, Common stock |
Biotechnology
Radiopharmaceuticals, Miniprotein Conjugates |
1.76B | 36 | 0.69 | 85 | 90 | - |
| VIR NASDAQ Vir Biotechnology |
Biotechnology
Hepatitis Therapy, Oncology Treatments, Influenza |
1.69B | 40 | 0.03 | 69 | 91 | - |
| ZBIO NASDAQ Zenas BioPharma, Common |
Biotechnology
Monoclonal Antibodies, Fusion Proteins |
1.67B | 45 | 0.09 | 65 | 93 | - |
| MAZE NASDAQ Maze Therapeutics, Common |
Pharmaceuticals
Kidney Disease, Metabolic Disease, Small |
1.65B | 40 | 0.13 | 69 | 86 | - |
| FTRE NASDAQ Fortrea Holdings |
Life Sciences Tools
Clinical Trials, Clinical Pharmacology |
1.65B | 40 | 1.14 | 38 | 97 | - |
| INVA NASDAQ Innoviva |
Pharmaceuticals
Respiratory Inhalers, Critical Care, Antibiotics |
1.62B | 51 | 0.02 | 75 | 46 | - |
| AVBP NASDAQ ArriVent BioPharma, Common |
Biotechnology
Oncology, Kinase Inhibitors, Antibody Conjugates |
1.61B | 44 | -0.05 | 70 | 92 | - |
| IMCR NASDAQ Immunocore Holdings |
Biotechnology
KIMMTRAK, Tebentafusp, Brenetafusp, IMC-R117C |
1.61B | 36 | -0.13 | 73 | 29 | - |
| MPLT NASDAQ MapLight Therapeutics |
Biotechnology
Schizophrenia, Alzheimers, Autism, Parkinsons |
1.59B | 47 | 1.16 | 76 | 97 | - |
| MLTX NASDAQ MoonLake Immunotherapeutics |
Biotechnology
Nanobody, Dermatology, Rheumatology, Inflammation |
1.58B | 32 | -0.28 | 77 | 77 | - |
| PHM MC Pharma Mar S.A. |
Biotechnology
Oncology Drugs, Marine Compounds, RNA |
1.56B | 52 | -0.12 | 78 | 49 | - |
| NVAX NASDAQ Novavax |
Biotechnology
Coronavirus Vaccines, Malaria Vaccines, Vaccine |
1.53B | 32 | -0.57 | 41 | 70 | - |
| SEPN NASDAQ Septerna, Common Stock |
Pharmaceuticals
Hypoparathyroidism, Urticaria, Graves, Metabolic |
1.53B | 46 | 1.10 | 41 | 96 | - |
| COAG NASDAQ Hemab Therapeutics |
Biotechnology
HMB-001, HMB-002, Coagulation Therapies |
1.45B | 21 | 0.57 | 74 | 16 | - |
| INBX NASDAQ Inhibrx Biosciences |
Biotechnology
Oncology, Biologics, Cancer Treatments, Solid |
1.43B | 40 | 1.03 | 36 | 99 | - |
| IMTX NASDAQ Immatics |
Biotechnology
Cell Therapies, TCR Bispecifics, Immunotherapies |
1.36B | 31 | -0.70 | 35 | 67 | - |
| MNKD NASDAQ MannKind |
Biotechnology
Inhaled Insulin, Insulin Delivery, Hypertension |
1.32B | 30 | 0.32 | 36 | 66 | - |
| AVLN NASDAQ Avalyn Pharma Common Stock |
Biotechnology
Inhaled Pirfenidone, Inhaled Nintedanib |
1.32B | 15 | -0.96 | 41 | 18 | - |
| ARDX NASDAQ Ardelyx |
Biotechnology
Gastrointestinal Drug, Renal Therapy, Phosphate |
1.30B | 26 | -1.06 | 40 | 24 | - |
| CAPR NASDAQ Capricor Therapeutics |
Biotechnology
Deramiocel, Cell Therapy, Exosome Vaccines |
1.30B | 45 | -0.65 | 78 | 89 | - |
| MGTX NASDAQ MeiraGTx Holdings |
Biotechnology
Gene Therapy, Ocular Treatments |
1.29B | 37 | 0.43 | 32 | 94 | - |
| CRVS NASDAQ Corvus Pharmaceuticals |
Biotechnology
Soquelitinib, Ciforadenant, Mupadolimab |
1.28B | 43 | 0.12 | 67 | 98 | - |
| SVRA NASDAQ Savara |
Biotechnology
Biopharmaceuticals, Respiratory Treatments |
1.27B | 48 | -0.83 | 54 | 91 | - |
| WVE NASDAQ Wave Life Sciences |
Pharmaceuticals
RNA Editing, RNA Interference, Antisense |
1.20B | 27 | 0.28 | 76 | 7 | - |
| EYPT NASDAQ Eyepoint Pharmaceuticals |
Pharmaceuticals
Retinal Therapeutics, Sustained Delivery, Macular |
1.20B | 26 | -1.16 | 38 | 42 | - |
| DRTS NASDAQ Alpha Tau Medical |
Biotechnology
Radiation Therapy, Solid Tumor Therapy, Cancer |
1.20B | 39 | 0.32 | 75 | 99 | - |
| MEDCL PA Medincell |
Biotechnology
Long-Acting Injections, Schizophrenia Treatment |
1.17B | 29 | 0.20 | 36 | 83 | - |
| ORIC NASDAQ Oric Pharmaceuticals |
Biotechnology
EGFR Inhibitors, HER2 Inhibitors, Prostate |
1.13B | 28 | 0.04 | 69 | 45 | - |
| SANA NASDAQ Sana Biotechnology |
Biotechnology
Cell Therapy, Type 1 Diabetes, Autoimmune |
1.12B | 27 | 0.15 | 59 | 61 | - |
| VOR NASDAQ Vor Biopharma |
Biotechnology
Fusion Protein, Autoimmune Therapies, Biologics |
1.12B | 42 | -0.03 | 81 | 20 | - |
| XNCR NASDAQ Xencor |
Biotechnology
Oncology, Autoimmune, Bispecific Antibodies |
1.11B | 35 | -0.38 | 73 | 85 | - |
| OLMA NASDAQ Olema Pharmaceuticals |
Biotechnology
Oncology, Breast Cancer, Estrogen Receptor |
1.10B | 41 | -0.30 | 69 | 72 | - |
| CGEM NASDAQ Cullinan Oncology |
Biotechnology
Bispecific Antibodies, Autoimmune Therapies |
1.08B | 49 | 0.45 | 70 | 96 | - |
| SLDB NASDAQ Solid Biosciences |
Biotechnology
Gene Therapy, Muscular Dystrophy, Cardiac |
1.07B | 46 | 0.25 | 67 | 96 | - |
| LXRX NASDAQ Lexicon Pharmaceuticals |
Biotechnology
Sotagliflozin, Heart Failure, Diabetes, Obesity |
1.03B | 40 | 0.56 | 39 | 96 | - |
| ABUS NASDAQ Arbutus Biopharma |
Biotechnology
RNAI Therapeutics, PD-L1 Inhibitor, HBV |
982M | 56 | -0.18 | 31 | 74 | - |
| DSGN NASDAQ Design Therapeutics |
Biotechnology
Friedreich Ataxia, Myotonic Dystrophy, Fuchs |
977M | 52 | 0.86 | 82 | 97 | - |
| DBV PA DBV Technologies S.A. |
Biotechnology
Epicutaneous Immunotherapy, Peanut Allergy, Milk |
977M | 28 | -0.44 | 40 | 36 | - |
| ANNX NASDAQ Annexon |
Biotechnology
Monoclonal Antibody, Antigen-Binding Fragment |
977M | 46 | 0.97 | 64 | 91 | - |
| LBRX NASDAQ LB Pharmaceuticals Common |
Pharmaceuticals
LB-102, Schizophrenia Treatment, Bipolar |
958M | 40 | 1.07 | 54 | 94 | - |
| KURA NASDAQ Kura Oncology |
Biotechnology
Menin Inhibitors, Cancer Drugs, Solid Tumors |
957M | 36 | 0.58 | 34 | 88 | - |
| REPL NASDAQ Replimune |
Biotechnology
Oncolytic Immunotherapy, Solid Tumor Treatment |
942M | 42 | 0.61 | 70 | 92 | - |
| DBVT NASDAQ DBV Technologies |
Biotechnology
Peanut Allergy, Milk Allergy, Celiac Disease |
936M | 35 | 0.14 | 74 | 44 | - |
| ANRO NYSE Alto Neuroscience |
Pharmaceuticals
Antidepressants, Schizophrenia Therapy |
920M | 44 | 1.19 | 76 | 99 | - |
| JANX NASDAQ Janux Therapeutics |
Biotechnology
Cancer Immunotherapy, Prostate Cancer, Solid |
894M | 17 | -0.02 | 37 | 17 | - |
| PHAT NASDAQ Phathom Pharmaceuticals |
Pharmaceuticals
Gastrointestinal Drugs, Acid Reflux Treatment, H. |
893M | 26 | -1.12 | 39 | 25 | - |
| TBPH NASDAQ Theravance Biopharma |
Pharmaceuticals
Pulmonary, Neurology, Cardiovascular |
877M | 64 | -0.44 | 92 | 52 | - |
| SPRY NASDAQ ARS Pharmaceuticals |
Biotechnology
Epinephrine Spray, Anaphylaxis Treatment, Allergy |
850M | 14 | -0.65 | 31 | 7 | - |
| CTMX NASDAQ CytomX Therapeutics |
Biotechnology
Antibody-Drug Conjugates, T-Cell Engagers |
829M | 36 | -0.23 | 99 | 44 | - |
| ZVRA NASDAQ Zevra Therapeutics |
Biotechnology
ADHD Medication, Sleep Disorders, Metabolic |
826M | 74 | 1.11 | 71 | 89 | - |
| OCS NASDAQ Oculis Holding Ordinary |
Biotechnology
Eye Drops, Biopharmaceuticals, Neuroprotectants |
817M | 20 | -0.29 | 80 | 1 | - |
| ODTX NASDAQ Odyssey Therapeutics |
Biotechnology
Autoimmune Therapies, Inflammatory Treatments |
807M | 18 | -1.04 | 36 | 20 | - |
| XOMA NASDAQ XOMA Royalty |
Biotechnology
Biotech Royalties, Clinical Assets, Therapeutic |
775M | 55 | 0.57 | 38 | 86 | - |
| GNFT PA Genfit S.A. |
Life Sciences Tools
Liver Therapies, Diagnostic Tests, Metabolic |
739M | 38 | 1.56 | 32 | 99 | - |
| CLYM NASDAQ Climb Bio |
Biotechnology
Monoclonal Antibodies, Autoimmune Therapies |
739M | 49 | 0.99 | 66 | 99 | - |
| IMMX NASDAQ Immix Biopharma |
Biotechnology
CAR Cell Therapy, NXC-201, Amyloidosis |
736M | 46 | 1.25 | 70 | 99 | - |
| ALLO NASDAQ Allogene Therapeutics |
Biotechnology
Cell Therapy, Oncology, Immunotherapy, Autoimmune |
721M | 40 | 0.92 | 67 | 80 | - |
| CADL NASDAQ Candel Therapeutics |
Biotechnology
Oncology, Immunotherapy, Viral Therapy, Solid |
720M | 47 | -0.12 | 76 | 96 | - |
| AURA NASDAQ Aura Biosciences |
Biotechnology
Ocular Oncology, Bladder Cancer, Solid Tumors |
718M | 27 | -0.27 | 62 | 59 | - |
| RIGL NASDAQ Rigel Pharmaceuticals |
Biotechnology
TAVALISSE, REZLIDHIA, GAVRETO |
716M | 56 | 0.96 | 36 | 90 | - |
| TECX NASDAQ Tectonic Therapeutic |
Biotechnology
TX45, TX2100, Bispecifics, GPCR Modulators |
716M | 48 | -0.06 | 84 | 94 | - |
| NGNE NASDAQ Neurogene |
Biotechnology
Gene Therapy, Rett Syndrome, Batten Disease, Rare |
704M | 44 | 0.90 | 76 | 95 | - |
| PRME NASDAQ Prime Medicine, Common Stock |
Biotechnology
Gene Editing, Prime Editing, Genetic Medicines |
699M | 23 | -0.90 | 57 | 26 | - |
| CRMD NASDAQ CorMedix |
Pharmaceuticals
Antimicrobial Therapies, Biopharmaceuticals |
690M | 48 | -0.58 | 44 | 20 | - |
| RGNX NASDAQ Regenxbio |
Biotechnology
Ophthalmology, Muscular Dystrophy, Rare Diseases |
687M | 35 | -0.02 | 38 | 90 | - |
| OMER NASDAQ Omeros |
Pharmaceuticals
Complement Inhibitors, Immunologic Therapeutics |
681M | 68 | 0.60 | 41 | 93 | - |
| FDMT NASDAQ 4D Molecular Therapeutics |
Biotechnology
Retinal Therapies, Cystic Fibrosis, Lung Disease |
680M | 46 | -0.51 | 64 | 95 | - |
| TRAX NASDAQ First Tracks Biotherapeutics |
Biotechnology
CD122 Antagonist, T Cell Depletion, BDCA2 |
673M | 42 | 0.39 | 74 | 83 | - |
| STTK NASDAQ Shattuck Labs |
Biotechnology
Monoclonal Antibodies, Oncology, Inflammatory |
673M | 48 | 0.93 | 77 | 99 | - |
| DRUG NASDAQ Bright Minds Biosciences |
Biotechnology
Epilepsy, Neuropsychiatry, Serotonin Agonists |
663M | 41 | -0.31 | 85 | 67 | - |
| EIKN NASDAQ Eikon Therapeutics, Common |
Biotechnology
Immunotherapy, Cancer Inhibitors, Receptor |
663M | 21 | -0.50 | 48 | 25 | - |
| RLMD NASDAQ Relmada Therapeutics |
Pharmaceuticals
NDV-01, Sepranolone, Bladder Cancer, Neurosteroid |
659M | 46 | 0.51 | 74 | 99 | - |
| ACHV NASDAQ Achieve Life Sciences |
Biotechnology
Smoking Cessation, Nicotine Therapy |
657M | 53 | 1.04 | 72 | 97 | - |
| MNPR NASDAQ Monopar Therapeutics |
Biotechnology
Wilson Disease, Oncology Therapeutics |
637M | 46 | 0.86 | 85 | 94 | - |
| BBOT NASDAQ BridgeBio Oncology |
Biotechnology
Cancer Therapeutics, Small Molecules, KRAS |
625M | 18 | -0.75 | 48 | 8 | - |
| ALT NASDAQ Altimmune |
Biotechnology
Liver Disease, Obesity Treatment, Alcohol Use |
615M | 31 | -0.34 | 93 | 6 | - |
| MDXG NASDAQ MiMedx |
Biotechnology
Wound Care, Surgical Repair, Burn Treatment |
581M | 37 | 0.03 | 85 | 7 | - |
| ASMB NASDAQ Assembly Biosciences |
Biotechnology
Genital Herpes, Hepatitis Delta, Hepatitis B |
573M | 35 | -0.31 | 56 | 56 | - |
| CTNM NASDAQ Contineum Therapeutics |
Pharmaceuticals
Small Molecules, A1R Inhibitors, M1R Inhibitors |
565M | 45 | 0.10 | 66 | 95 | - |
| ZURA NASDAQ Zura Bio Ordinary Shares |
Biotechnology
Immunology, Inflammation, Bispecific Antibodies |
560M | 47 | -0.19 | 71 | 94 | - |
| ARVN NASDAQ Arvinas |
Pharmaceuticals
Oncology, Neuroscience, Breast Cancer, Prostate |
541M | 14 | -0.18 | 31 | 9 | - |
| OCGN NASDAQ Ocugen |
Biotechnology
Gene Therapies, Vaccines, Regenerative Medicine |
518M | 33 | -0.18 | 64 | 27 | - |
| KYTX NASDAQ Kyverna Therapeutics |
Biotechnology
Cell Therapy, CAR T-Cell, Autoimmune Treatment |
513M | 48 | -0.23 | 63 | 95 | - |
| PRTA NASDAQ Prothena |
Biotechnology
Parkinson Disease, Alzheimer Disease |
507M | 40 | -0.47 | 62 | 42 | - |
| OVID NASDAQ Ovid Therapeutics |
Biotechnology
Epilepsy Drugs, Psychosis Drugs, Brain Medicines |
506M | 48 | 0.87 | 76 | 99 | - |
| STRO NASDAQ Sutro Biopharma |
Biotechnology
STRO: Antibody Conjugates, Pneumonia Vaccines |
504M | 50 | 0.71 | 35 | 99 | - |
| EDIT NASDAQ Editas Medicine |
Biotechnology
Genome Editing, LDL Cholesterol, Sickle Cell |
497M | 28 | 0.08 | 35 | 85 | - |
| SLN NASDAQ Silence Therapeutics |
Biotechnology
Hematology, Cardiovascular, Renal, Metabolic |
491M | 41 | 0.17 | 38 | 96 | - |
| CCCC NASDAQ C4 Therapeutics |
Biotechnology
Cemsidomide, CFT8919, Antibody Conjugates |
475M | 44 | 0.83 | 40 | 97 | - |
| RZLT NASDAQ Rezolute |
Biotechnology
Rare Disease, Monoclonal Antibody |
473M | 39 | 0.38 | 90 | 82 | - |
| ARTV NASDAQ Artiva Biotherapeutics |
Biotechnology
Cell Therapy, Oncology Treatments, Autoimmune |
471M | 49 | 0.68 | 71 | 99 | - |
| SGMT NASDAQ Sagimet Biosciences Series |
Biotechnology
FASN Inhibitors, MASH Treatment, Acne Therapy |
470M | 31 | -0.28 | 75 | 77 | - |
| FBRX NASDAQ Forte Biosciences |
Biotechnology
FB-102, Autoimmune Therapies, Monoclonal |
428M | 36 | -0.14 | 68 | 63 | - |
| RCKT NASDAQ Rocket Pharmaceuticals |
Biotechnology
Gene Therapy, Rare Diseases, Cardiac Programs |
419M | 39 | -0.14 | 69 | 71 | - |
| HELP NASDAQ Cybin Common Stock |
Pharmaceuticals
Psilocybin Analogs, DMT Therapeutics, Depression |
410M | 23 | -0.42 | 81 | 21 | - |
| CMPX NASDAQ Compass Therapeutics |
Biotechnology
Bispecific Antibodies, Monoclonal Antibodies |
409M | 25 | -0.22 | 72 | 1 | - |
| UPB NASDAQ Upstream Bio |
Biotechnology
Inflammatory Treatments, Respiratory Therapies |
409M | 33 | 0.08 | 91 | 1 | - |
| VSTM NASDAQ Verastem |
Biotechnology
Oncology Therapeutics, Kinase Inhibitors, Small |
395M | 16 | -0.20 | 32 | 6 | - |
| VNDA NASDAQ Vanda Pharmaceuticals |
Biotechnology
Antipsychotics, Sleep Therapeutics, Multiple |
373M | 34 | 0.25 | 60 | 23 | - |
| ABEO NASDAQ Abeona Therapeutics |
Biotechnology
Gene Therapy, Cell Therapy, Rare Diseases |
360M | 46 | 0.50 | 37 | 77 | - |
| LXEO NASDAQ Lexeo Therapeutics, Common |
Biotechnology
Gene Therapy, Cardiac Medicines, Alzheimers |
349M | 21 | -0.44 | 67 | 4 | - |
| IRD NASDAQ Opus Genetics |
Pharmaceuticals
Gene Therapies, Retinal Therapies, Ophthalmic |
345M | 43 | 0.93 | 66 | 96 | - |
| IMRX NASDAQ Immuneering |
Biotechnology
Oncology Drugs, MEK Inhibitor, Pancreatic Cancer |
336M | 28 | -0.20 | 84 | 16 | - |
| LRMR NASDAQ Larimar Therapeutics |
Biotechnology
CTI-1601, Friedreichs Ataxia, Peptide |
333M | 25 | -0.38 | 67 | 8 | - |
| FATE NASDAQ Fate Therapeutics |
Biotechnology
Cell Therapy, Immunotherapy, Cancer Treatment |
315M | 45 | 1.13 | 42 | 99 | - |
| RNAC NASDAQ Cartesian Therapeutics |
Biotechnology
Cell Therapy, Autoimmune Care, Oncology Pipeline |
311M | 13 | 0.08 | 32 | 78 | - |
| ELDN NASDAQ Eledon Pharmaceuticals |
Biotechnology
Immunosuppressants, Organ Transplantation, ALS |
304M | 42 | 0.06 | 71 | 90 | - |
| FULC NASDAQ Fulcrum Therapeutics |
Pharmaceuticals
Biopharmaceuticals, Small Molecules, Sickle Cell |
243M | 20 | -0.19 | 85 | 1 | - |
| QTTB NASDAQ Q32 Bio |
Biotechnology
Monoclonal Antibody, Fusion Protein, Complement |
222M | 70 | 1.10 | 83 | 99 | - |
| KPTI NASDAQ Karyopharm Therapeutics |
Biotechnology
Oncology Drugs, Nuclear Export Inhibitors, SINE |
216M | 47 | 0.59 | 43 | 93 | - |
| LENZ NASDAQ LENZ Therapeutics |
Biotechnology
Presbyopia Treatment, Eye Care Therapies |
182M | 24 | -0.12 | 75 | 1 | - |
| CRBU NASDAQ Caribou Biosciences |
Biotechnology
Genome Editing, CAR-T Therapy, Oncology |
181M | 26 | -0.31 | 36 | 39 | - |
| CRBP NASDAQ Corbus Pharmaceuticals |
Biotechnology
Oncology, Obesity, Antibody Conjugates |
171M | 27 | -0.45 | 73 | 23 | - |
| NRXP NASDAQ NRX Pharmaceuticals |
Biotechnology
Antidepressants, Ketamine Therapies, Bipolar |
165M | 49 | 0.92 | 80 | 91 | - |
| ALDX NASDAQ Aldeyra The |
Biotechnology
Eye Treatments, Respiratory Treatments, Drug |
138M | 19 | 0.35 | 79 | 11 | - |
| BDTX NASDAQ Black Diamond Therapeutics |
Biotechnology
Oncology, Targeted Therapies, Lung Cancer, Brain |
115M | 23 | -0.69 | 67 | 5 | - |
Technical
Structure
Fundamental
Topics in Industry »Biotechnology« (258)
- Oncology
- Monoclonal Antibodies
- Cell Therapy
- Gene Therapy
- Immunology
- Autoimmune Therapies
- Rare Diseases
- Immunotherapy
- Small Molecules
- Kinase Inhibitors
- Solid Tumors
- Bispecific Antibodies
- Epilepsy
- Biologics
- Cancer Therapeutics
- Biopharmaceuticals
- Rare Disease
- Oncology Therapeutics
- Infectious Disease
- Hematology
- Lung Cancer
- Metabolic Treatments
- Autoimmune
- Cell Therapies
- Oncology Treatments
- Antibody Conjugates
- Monoclonal Antibody
- Oncology Drugs
- Cystic Fibrosis
- Sickle Cell